EDIT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Editas Medicine Inc

Watchlist Manager

Watchlist

Price: 3.115 USD 5.95% Market Closed

Market Cap: $522.7m

	Editas Medicine Inc NASDAQ:EDIT	US
	Shield Therapeutics PLC LSE:STX	UK
B	Bebida Beverage Co OTC:BBDA	US
	DevEx Resources Ltd ASX:DEV	AU
C	Casino Guichard Perrachon SA DUS:CAJ	FR
F	Finbond Group Ltd JSE:FGL	ZA
	Satori Resources Inc XTSX:BUD	CA
	BJ's Restaurants Inc NASDAQ:BJRI	US
	MustGrow Biologics Corp XTSX:MGRO	CA
M	MIX Telematics Ltd JSE:MIX	ZA
	Prodware SA PAR:ALPRO	FR
	Compagnie Financiere Tradition SA SIX:CFT	CH
	West Bancorporation Inc NASDAQ:WTBA	US
	ASML Holding NV AEX:ASML	NL
	Image Scan Holdings PLC LSE:IGE	UK
	Heineken Holding NV AEX:HEIO	NL
B	B Communications Ltd TASE:BCOM	IL
B	BluGlass Ltd OTC:BUGLF	AU

Profitability Summary

Editas Medicine Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-178%

Negative 3Y Average Operating Margin

-388%

Operating Margin is Increasing

-1 118% > -178%

Negative Net Margin

-157%

Negative 3Y Average Net Margin

-430%

Net Margin is Increasing

-1 065% > -157%

Negative Free Cash Flow Margin

-256%

Negative 3Y Average Free Cash Flow Margin

-402%

Free Cash Flow Margin is Increasing

-876% > -256%

Negative ROE

-119%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-227%

Declining ROIC

-193% > -360%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.